Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma
Cancers · 23.08.2025 · 17 (17) · 2740
DOI: 10.3390/cancers17172740 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 23.08.2025. Verfasst von Tomáš Crha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Hospital Brno and Faculty of Medicine, Masaryk University, 60200 Brno, Czech Republic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic—RVO.
Abstract (Originalsprache)
Background
Endometrial carcinoma is the most common gynaecological malignant tumour in developed countries. At present, no routinely used serum biomarker is available for the prediction of lymph node metastasis (LNM). This study thus evaluates the potential of tumour markers CA125 and HE4 as LNM predictors in endometrial carcinoma patients.
Objectives
The aim of this study was to evaluate the potential use of CA125 and HE4 and to assess the viability of a model developed using the parameters of serum tumour marker levels for LNM risk stratification.
Methods
A retrospective, single-institution study of 220 patients with biopsy-proven endometrial carcinoma was conducted from May 2020 to December 2023. Preoperative serum levels of HE4 and CA125 were determined. All patients underwent surgical lymph node staging. The study evaluated the sensitivity and specificity of tumour markers and of the developed LNM risk prediction model.
Results
No LNM was observed in 167 of the 220 patients (75.9%), micrometastatic lymph node involvement was observed in 13 patients (5.9%), and macrometastatic involvement was observed in 24 patients (10.9%). Median CA125 and HE4 levels were significantly higher in patients with LNM than in those without. With a CA125 cut-off value of 35 IU/mL, a sensitivity of 70% and a specificity of 92% were obtained, while an HE4 cut-off value of 103 pmol/L yielded a sensitivity of 78% and a specificity of 80%. A prediction model combining CA125, HE4, and the extent of uterine invasion, as detected by ultrasound, yielded a sensitivity of 84% and a specificity of 98% in predicting LNM.
Conclusions
CA125 and HE4, along with the prediction model, facilitate endometrial carcinoma patient subdivision into low- and high-risk LNM groups. As this method is technically simple, non-invasive, and inexpensive, it could be of undeniable benefit in the risk stratification of patients with multiple comorbidities, which limit the duration and extent of surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, University Hospital Brno and Faculty of Medicine, Masaryk University, 60200 Brno, Czech Republic.
- Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic.
- Department of Laboratory Medicine, Masaryk University and University Hospital Brno, 62500 Brno, Czech Republic.
- Department of Laboratory Methods, Masaryk University, 62500 Brno, Czech Republic.
- Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, 60200 Brno, Czech Republic.
ORCID-Profile: Tomáš Crha, Petra Ovesná, Vít Weinberger, Michal Felsinger, Branislav Babjak, Dalibor Valík, Jitka Hausnerová, Luboš Minář
Förderung
- Ministry of Health of the Czech Republic—RVO
Zitieren
APA
Crha, T., Ovesná, P., Weinberger, V., Felsinger, M., Babjak, B., Valík, D., Hausnerová, J., & Minář, L. (2025). Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma. Cancers, 17(17), 2740. https://doi.org/10.3390/cancers17172740
Vancouver
Crha T, Ovesná P, Weinberger V, Felsinger M, Babjak B, Valík D, et al. Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma. Cancers. 2025;17(17):2740. doi:10.3390/cancers17172740
BibTeX
@article{Crha2025,
author = {Crha, Tomáš and Ovesná, Petra and Weinberger, Vít and Felsinger, Michal and Babjak, Branislav and Valík, Dalibor and Hausnerová, Jitka and Minář, Luboš},
title = {Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma},
journal = {Cancers},
year = {2025},
volume = {17},
number = {17},
pages = {2740},
doi = {10.3390/cancers17172740}
}
EUVIMED